Skip to main content

Ethics and Responsibility

At Amylyx, people living with neurodegenerative diseases are our true north -- by doing the right thing, we will do the right thing by them.

Amylyx is committed to conducting business in an ethical and lawful way. We strive to foster a “speak up” culture and encourage employees and third parties to ask questions or report potential instances of inappropriate activity without fear of retribution. We take violations of our Code of Conduct seriously, and thoroughly investigate known cases and take disciplinary action as appropriate.

You may raise any concerns or questions by notifying your manager, Human Resources, Legal, Compliance or through the Amylyx Compliance Helpline. Helpline reports may be communicated anonymously and confidentially 24/7 via the phone number or the website listed below:

For country specific helpline phone numbers visit the online portal.

California Comprehensive Compliance Program Declaration

Amylyx declares, based on our good faith understanding of the California Health and Safety Codes §§ 119400-119402, and to the best of our knowledge, that we are in substantial compliance with our Comprehensive Compliance Program (“Compliance Program”) and California Health and Safety Code §§ 119400-119402. Our Compliance Program includes the elements of an effective compliance program identified in the “Compliance Program Guidance for Pharmaceutical Manufacturers” published by the Office of the Inspector General, U.S. Department of Health and Human Services (“HHS-OIG Guidance”). Consistent with our understanding of the California Health and Safety Code, this declaration is limited to Amylyx’ activities directed to California.

Statutory Price Disclosure for Colorado Prescribers Pursuant to Colorado House Bill 19-1131

This information in this form is being provided pursuant to Colorado HB 19-1131. The information is accurate as of November 30, 2022.